Advertisement

Ads Placeholder
Loading...

Dynavax Technologies Corporation

DVAX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$15.50
$0.00(0.00%)
U.S. Market is Open • 14:51

Dynavax Technologies Corporation (DVAX) Stock Overview

Explore Dynavax Technologies Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio-41.89
EPS (TTM)$-0.37
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$17.42
3 Months$12.82
1 Year Target$12.13

DVAX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dynavax Technologies Corporation (DVAX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $12.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -41.89 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
43.52%
6-Month Change
64.72%
Year-to-Date (YTD) Change
0.78%
1-Year Change
13.22%
3-Year Change
58.81%
5-Year Change
51.81%
All-Time (Max) Change
-83.51%

Contact Information

https://www.dynavax.com
510 848 5100
2100 Powell Street, EmeryVille, CA, 94608

Company Facts

4,050 Employees
IPO DateFeb 19, 2004
CountryUS

Frequently Asked Questions